Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review

  • ID: 1314761
  • SWOT Analysis
  • 84 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Beckman Coulter Inc
  • Becton Dickinson and Co
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corp
  • Edwards Lifesciences Corp
  • Eli Lilly and Co
  • MORE
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Abbott Laboratories (Abbott) develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s products comprise specialized medicines; medical diagnostic instruments and tests; minimally invasive surgical devices; nutritional supplements for infants, children and adults; and products for veterinary care. It has research and development, manufacturing and administrative facilities across the world. The company markets its products in North America, Latin America, the Caribbean, the Middle East, Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.

Abbott Laboratories Key Recent Developments

Feb 06, 2018: ANGLE: Research Grant From Abbott
Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results
Oct 30, 2017: Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease With Xience Stent Felt Better Faster and Had Similar Long-Term Outcomes to Open-Heart Surgery
Oct 18, 2017: Abbott Reports Third-Quarter 2017 Results
Sep 22, 2017: Abbott and the Abbott Fund Provide $2 Million in Additional Relief to Help Families Affected by Hurricane Maria and the Earthquake in Central Mexico

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Beckman Coulter Inc
  • Becton Dickinson and Co
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corp
  • Edwards Lifesciences Corp
  • Eli Lilly and Co
  • MORE
Section 1 - About the Company
  • Abbott Laboratories - Key Facts
  • Abbott Laboratories - Key Employees
  • Abbott Laboratories - Key Employee Biographies
  • Abbott Laboratories - Major Products and Services
  • Abbott Laboratories - History
  • Abbott Laboratories - Company Statement
  • Abbott Laboratories - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Abbott Laboratories - Business Description
  • Business Segment: Cardiovascular and Neuromodulation Products
  • Overview
  • Performance
  • Business Segment: Diagnostics
  • Overview
  • Performance
  • Business Segment: Established Pharmaceutical Products
  • Overview
  • Performance
  • Business Segment: Nutritionals
  • Overview
  • Performance
  • Business Segment: Other Products
  • Overview
  • Performance
  • Geographical Segment: All Other Countries
  • Performance
  • Geographical Segment: Brazil
  • Performance
  • Geographical Segment: Canada
  • Performance
  • Geographical Segment: China
  • Performance
  • Geographical Segment: Colombia
  • Performance
  • Geographical Segment: Germany
  • Performance
  • Geographical Segment: India
  • Performance
  • Geographical Segment: Italy
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: Netherlands
  • Performance
  • Geographical Segment: Russia
  • Performance
  • Geographical Segment: Switzerland
  • Performance
  • Geographical Segment: United Kingdom
  • Performance
  • Geographical Segment: US
  • Performance
  • Geographical Segment: Vietnam
  • Performance
  • R&D Overview
  • Abbott Laboratories - SWOT Analysis
  • SWOT Analysis - Overview
  • Abbott Laboratories - Strengths
  • Abbott Laboratories - Weaknesses
  • Abbott Laboratories - Opportunities
  • Abbott Laboratories - Threats
  • Abbott Laboratories - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Abbott Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Abbott Laboratories, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Abbott Laboratories, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Feb 25, 2018: Abbott: 'Top Innovator' With 20 Breakthroughs
  • Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results
  • Nov 29, 2017: Solvay unveils Zeniva ZA-600 CF30 PEEK, a high-strength, injection moldable polymer for implantable devices
  • Oct 30, 2017: Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease With Xience Stent Felt Better Faster and Had Similar Long-Term Outcomes to Open-Heart Surgery
  • Oct 18, 2017: Abbott Reports Third-Quarter 2017 Results
  • Sep 29, 2017: Alere Announces the U.S. Department of Justice Closes Investigation
  • Sep 28, 2017: Alere Announces Settlement with SEC
  • Sep 28, 2017: Alere Announces Agreement in Principle to Settle with the U.S. Department of Justice
  • Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With $1 Million to Help Families Affected by Hurricane Irma
  • Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Abbott Laboratories, Key Facts
  • Abbott Laboratories, Key Employees
  • Abbott Laboratories, Key Employee Biographies
  • Abbott Laboratories, Major Products and Services
  • Abbott Laboratories, History
  • Abbott Laboratories, Other Locations
  • Abbott Laboratories, Subsidiaries
  • Abbott Laboratories, Key Competitors
  • Abbott Laboratories, Ratios based on current share price
  • Abbott Laboratories, Annual Ratios
  • Abbott Laboratories, Annual Ratios
  • Abbott Laboratories, Annual Ratios
  • Abbott Laboratories, Interim Ratios
  • Abbott Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Abbott Laboratories, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Abbott Laboratories, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Abbott Laboratories, Performance Chart (2013 - 2017)
  • Abbott Laboratories, Ratio Charts
  • Abbott Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Abbott Laboratories, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Siemens Healthcare GmbH
  • Medtronic Plc
  • Health Discovery Corp
  • GlaxoSmithKline Plc
  • F. Hoffmann-La Roche Ltd
  • Eli Lilly and Co
  • Edwards Lifesciences Corp
  • Boston Scientific Corp
  • Boehringer Ingelheim GmbH
  • Becton Dickinson and Co
  • Beckman Coulter Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll